A3230

AR-A014418

≥98% (HPLC), solid

• 别名: N-(4-Methoxybenzyl)-N′-(5-nitro-1,3-thiazol-2-yl)urea
• 经验公式（希尔记法）: C₁₂H₁₂N₄O₄S
• CAS号: 487021-52-3
• 分子量: 308.31
• MDL编号: MFCD08277040
• UNSPSC代码: 12352200
• PubChem化学物质编号: 329770820
• NACRES: NA.77

属性

• 质量水平: 100
• 方案: ≥98% (HPLC)
• 表单: solid
• 颜色: off-white to tan
• 溶解性: DMSO: ≥20 mg/mL, clear, light yellow; H₂O: insoluble
• 创始人: AstraZeneca
• 储存温度: 2-8°C
• SMILES字符串: COc1ccc(CNC(=O)Nc2ncc(s2)[N+]([O-])=O)cc1
• InChI: 1S/C12H12N4O4S/c1-20-9-4-2-8(3-5-9)6-13-11(17)15-12-14-7-10(21-12)16(18)19/h2-5,7H,6H2,1H3,(H2,13,14,15,17)
• InChI key: YAEMHJKFIIIULI-UHFFFAOYSA-N

说明

一般描述

AR-A014418 may have chronic pain-relieving properties. In mice having neuropathic pain, this molecule has been shown to have antihyperalgesic effects. AR-A014418 may modulate proinflammatory cytokines and the catecholaminergic and serotonergic pathways. It has also been studied that AR-A014418 inhibits growth of pancreatic cancer cells.

应用

AR-A014418 has been used as an inhibitor of glycogen synthase kinase 3 (GSK3).

生化/生理作用

AR-A014418 is a glycogen synthase kinase 3 (GSK3) inhibitor.

Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer′s disease. GSK3 inhibitor, AR-A014418, inhibits GSK3 (IC₅₀ = 104 nM), in an ATP-competitive manner (Ki = 38 nM). AR-A014418 does not significantly inhibit cdk2 or cdk5 (IC₅₀ > 100 μM) or 26 other kinases, demonstrating high specificity for GSK3.

特点和优势

This compound is featured on the PKB/Akt page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

安全信息

• 储存分类代码: 11 - Combustible Solids
• WGK: WGK 3
• 个人防护装备: dust mask type N95 (US), Eyeshields, Gloves